RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,843 | $19,239 | $6,013 | $5,871 |
| - Cash | $150 | $1,283 | $722 | $760 |
| + Debt | $306 | $2,675 | $2,729 | $2,671 |
| Enterprise Value | $2,999 | $20,631 | $8,021 | $7,782 |
| Revenue | $87 | $572 | $526 | $508 |
| % Growth | -84.8% | 8.7% | 3.5% | – |
| Gross Profit | $73 | $485 | $438 | $406 |
| % Margin | 84.5% | 84.8% | 83.3% | 79.9% |
| EBITDA | -$12 | -$105 | -$169 | -$329 |
| % Margin | -14% | -18.4% | -32.2% | -64.7% |
| Net Income | -$14 | -$195 | -$254 | -$397 |
| % Margin | -16.4% | -34.2% | -48.3% | -78.1% |
| EPS Diluted | -0.025 | -0.37 | -0.46 | -0.74 |
| % Growth | 93.2% | 19.6% | 37.8% | – |
| Operating Cash Flow | $65 | -$57 | -$188 | -$279 |
| Capital Expenditures | -$8 | -$85 | -$36 | -$85 |
| Free Cash Flow | $57 | -$142 | -$224 | -$365 |